HNSCC is the seventh most common cancer worldwide. Approximately 600,000 new cases are diagnosed each year, including about 50,000 in the United States. HNSCC occurs most often …

Background: Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy often diagnosed in advanced stages. Despite advancements in therapy, it retains a high mortality …

2020年11月26日 · Head and neck squamous cell carcinomas (HNSCCs) develop from the mucosal epithelium in the oral cavity, pharynx and larynx and are the most common …

Effective therapies for advanced head and neck squamous cell carcinoma (HNSCC) are lacking. This article presents what is believed to be the first reported case of a patient harboring a MET …

Despite substantial advances in imaging, diagnostics, and treatment options for patients with head and neck squamous cell carcinoma (HNSCC), 5-year overall survival (OS) has only modestly …

2023年5月15日 · Purpose: The efficacy of cetuximab is poor in metastatic head and neck squamous cell carcinoma (HNSCC). Cetuximab initiates natural killer (NK) cell-mediated …

Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with platinum-refractory …

2019年8月7日 · Identification of effective targeted therapies for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) remains an unmet medical need. A patient with …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with 700,000 cases diagnosed per year.1 Although there have been advances in multimodality …

Head and neck squamous cell carcinomas (HNSCCs) develop from the mucosal epithelium in the oral cavity, pharynx and larynx and are the most common malignancies that arise in the head …